148 related articles for article (PubMed ID: 26453118)
21. Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer.
Lu K; Zhu Y; Sheng L; Liu L; Shen L; Wei Q
Hepatogastroenterology; 2011; 58(110-111):1507-10. PubMed ID: 21940318
[TBL] [Abstract][Full Text] [Related]
22. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.
Wang H; Gao J; Bai M; Liu R; Li H; Deng T; Zhou L; Han R; Ge S; Huang D; Ba Y
Platelets; 2014; 25(5):382-7. PubMed ID: 24001199
[TBL] [Abstract][Full Text] [Related]
23. Toward personalized treatment of advanced biliary tract cancers.
Geynisman DM; Catenacci DV
Discov Med; 2012 Jul; 14(74):41-57. PubMed ID: 22846202
[TBL] [Abstract][Full Text] [Related]
24. Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status.
Moriwaki T; Ishige K; Araki M; Yoshida S; Nishi M; Sato M; Yamada T; Yamamoto Y; Ozeki M; Ishida H; Yamaguchi T; Matsuda K; Murashita T; Abei M; Hyodo I
Med Oncol; 2014 Nov; 31(11):287. PubMed ID: 25316268
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
[TBL] [Abstract][Full Text] [Related]
26. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer.
Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M
Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352
[TBL] [Abstract][Full Text] [Related]
27. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
28. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
29. Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.
Yamashita H; Kitayama J; Kanno N; Yatomi Y; Nagawa H
BMC Cancer; 2006 Jun; 6():147. PubMed ID: 16740157
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic associations of preoperative plasma levels of fibrinogen and D-dimer after curative resection in patients with colorectal cancer].
Wang JF; Guo Z; Tang L; Guo JS; Hu J; Liu JZ
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):906-9. PubMed ID: 23863674
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
Ghezzi F; Cromi A; Siesto G; Giudici S; Serati M; Formenti G; Franchi M
Gynecol Oncol; 2010 Nov; 119(2):309-13. PubMed ID: 20688365
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
35. Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma.
Kim JH; Do IG; Kim K; Sohn JH; Kim HJ; Jeon WK; Lee SR; Son BH; Shin JH; Nam H; Kwon HJ; Kim MS; Hong HP; Serrero G; Koo DH;
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1085-1092. PubMed ID: 27744566
[TBL] [Abstract][Full Text] [Related]
36. Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
Pichler M; Dalpiaz O; Ehrlich GC; Stojakovic T; Martín Hernández JM; Mannweiler S; Pummer K; Zigeuner R; Hutterer GC
J Urol; 2014 Apr; 191(4):920-5. PubMed ID: 24513163
[TBL] [Abstract][Full Text] [Related]
37. Older adults with biliary tract cancer: treatment and prognosis.
Lee BS; Hwang JH; Lee SH; Jang SE; Ahn DW; Hwang DW; Cho JY; Yoon YS; Han HS; Ahn S
J Am Geriatr Soc; 2012 Oct; 60(10):1862-71. PubMed ID: 23035728
[TBL] [Abstract][Full Text] [Related]
38. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
39. A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
Filippi R; Montagnani F; Lombardi P; Fornaro L; Aprile G; Casadei-Gardini A; Faloppi L; Palloni A; Satolli MA; Scartozzi M; Citarella F; Lutrino SE; Vivaldi C; Silvestris N; Rovesti G; Rimini M; Aglietta M; Brandi G; Leone F
Acta Oncol; 2021 Oct; 60(10):1317-1324. PubMed ID: 34282710
[TBL] [Abstract][Full Text] [Related]
40. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment.
Wen J; Yang Y; Ye F; Huang X; Li S; Wang Q; Xie X
Breast; 2015 Dec; 24(6):745-50. PubMed ID: 26482138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
